ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,868.55
-0.22%
US Tech 100
20,406.40
-0.21%
Dow Jones
42,392.27
-0.36%
Brent Oil
75.855
2.71%
Bitcoin
96,863.23
2.62%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cadrenal Therapeutics Inc (CVKD)

  7. Cadrenal Therapeutics Inc (CVKD) News

CVKD

Cadrenal Therapeutics (CVKD)

Cadrenal Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CVKD
DateTimeSourceHeadlineSymbolCompany
12/31/20248:00AMBusiness WireCadrenal Therapeutics Provides 2024 Year-End Company Update, Reinforcing Clinical Development Plan for Tecarfarin in LVAD and Other Rare Cardiovascular IndicationsNASDAQ:CVKDCadrenal Therapeutics Inc
12/23/20244:44PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CVKDCadrenal Therapeutics Inc
12/20/20245:28PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CVKDCadrenal Therapeutics Inc
12/18/20249:00AMBusiness WireCadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week with Event Participation and Investor/Partner MeetingsNASDAQ:CVKDCadrenal Therapeutics Inc
11/25/20244:53PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CVKDCadrenal Therapeutics Inc
11/25/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CVKDCadrenal Therapeutics Inc
11/19/20249:00AMPR Newswire (US)Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech OutlookNASDAQ:CVKDCadrenal Therapeutics Inc
11/14/20244:05PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CVKDCadrenal Therapeutics Inc
11/14/20249:00AMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CVKDCadrenal Therapeutics Inc
11/12/20249:00AMPR Newswire (US)CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESSNASDAQ:CVKDCadrenal Therapeutics Inc
11/07/20244:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CVKDCadrenal Therapeutics Inc
11/07/20249:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
11/07/20249:00AMPR Newswire (US)CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATENASDAQ:CVKDCadrenal Therapeutics Inc
11/04/20244:41PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
11/04/20249:13AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CVKDCadrenal Therapeutics Inc
11/04/20249:13AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CVKDCadrenal Therapeutics Inc
11/01/20248:00PMPR Newswire (US)Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross ProceedsNASDAQ:CVKDCadrenal Therapeutics Inc
10/24/20249:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
10/24/20249:00AMPR Newswire (US)Cadrenal Therapeutics Raises $5.1 Million via At-The-Market FacilityNASDAQ:CVKDCadrenal Therapeutics Inc
10/23/20249:00AMPR Newswire (US)CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUMNASDAQ:CVKDCadrenal Therapeutics Inc
10/04/20244:15PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CVKDCadrenal Therapeutics Inc
09/25/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
09/23/20244:15PMPR Newswire (US)Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor ConferenceNASDAQ:CVKDCadrenal Therapeutics Inc
09/05/20244:59PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
08/22/20249:00AMPR Newswire (US)Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD PatientsNASDAQ:CVKDCadrenal Therapeutics Inc
08/20/20249:00AMPR Newswire (US)Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD PatientsNASDAQ:CVKDCadrenal Therapeutics Inc
08/20/20246:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
08/16/20246:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
08/14/20249:00AMPR Newswire (US)Cadrenal Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:CVKDCadrenal Therapeutics Inc
08/08/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CVKD

Your Recent History

USOTC
ASII
Accredited Solutions (PK)
NASDAQ
TSLA
Tesla
USOTC
AFFU
Affluence (PK)
NASDAQ
NVDA
NVIDIA
USOTC
TPTW
TPT Global Tech (CE)
USOTC
QNCCF
Quantum eMotion (QB)
USOTC
CEOS
CeCors (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
USOTC
PSRU
Valiant Eagle (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
FNMA
Fannie Mae (QB)
USOTC
SPZI
Spooz (PK)
NASDAQ
COOP
Mr Cooper
USOTC
APRU
Apple Rush (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads